The Change of Haemoglobin Levels in Hemodialysis Patient with The Provision of Nutritional Support
Main Article Content
Abstract
Background : Hemodialysis patients are at risk of anemia, malnutrition, and gastrointestinal disorders. Because of those many nutritional problems, hemodialysis patients need to obtain nutritional support of protein sources, which can be filled with catfish (Clarias sp.) abon. Objectives : This study aimed to determine the change of hemoglobin level in hemodialysis patients with the provision of nutritional support. Method : This was a quasi-experimental with the pre-post test design. The study was conducted at Panembahan Senopati General Hospital in Bantul during January–December 2017. Catfish abon was given to the eligible patients approximately 0.36 g/kgBW/day for 21 days. Subjects were 32 routine hemodialysis patients whose age are >18 years. The dependent variable was hemoglobin level, while the independent variable was the provision of catfish abon. Data were analyzed using univariate and bivariate with paired T-test. Results : The average of pre and post intervention hemoglobin level were 9.24±SD g/dl and 9.50±SD g/dl respectively. There were no differences on average hemoglobin level of hemodialysis patient (p=0.208). Conclusion: provision of nutritional support increases the average of hemoglobin level during the intervention, although it does not statistically affect the hemoglobin level of hemodialysis patients.
Downloads
Article Details
References
2. Harvinder, G.S., W.S.S. Chee, T. Karupaiah, S. Sahathevan, K. Chinna, A. Ghazali, S. Bavanandan, B.L. Goh., “Comparison of malnutrition prevalence between haemodialysis and continuous ambulatory peritoneal dialysis patients: a cross-sectional study,” Malaysian Journal of Nutrition, vol. 19, no. 3, p. 271–283, 2013.
3. Yin, P., Y. Song, J. Li., “Soluble transferrin receptor as a marker of erythropoiesis in patients undergoing high-flux hemodialysis,” Bosnian Journal of Basic Medical Sciences, vol. 17, no. 4, p. 333–338, 2017.
4. Ling, L.H.L., C.Y. Mun., “Correlations between anthropometric measurements, biochemical indicators, dietary intake and Dialysis Malnutrition Score among haemodialysis patients in Sibu, Sarawak,” Malaysian Journal of Nutrition, vol. 24, no. 2, p. 227–239, 2018.
5. Glassock, R.J., C. Winearls., “Ageing and the glomerular filtration rate : truths and consequences,” Transactions of The American Clinical and Climatological Association, vol. 120, p. 419–428, 2009.
6. Kamaluddin, R., E. Rahayu., “Analisis faktor-faktor yang mempengaruhi kepatuhan asupan cairan pada pasien gagal ginjal kronik dengan hemodialisis di RSUD Prof. Dr. Margono Soekarjo Purwokerto,” The Soedirman Journal of Nursing, vol. 4, no. 1, p. 20–31, 2009.
7. Notoatmojo, S., “Metodologi penelitian kesehatan,” Jakarta, Rineka Cipta, 2002.
8. Widiany, F.L., “Faktor-faktor yang mempengaruhi kepatuhan diet pasien hemodialisis,” Jurnal Gizi Klinik Indonesia, vol. 14, no. 2, p. 72–79, 2017.
9. Himmelfarb, J., “Hemodialysis complications.” American Journal of Kidney Diseases, vol. 45, no. 6, p. 1122–1131, 2005.
10. Jung, M.Y., S.Y. Hwang, Y.A. Hong, S.Y. Oh, J.H. Seo, Y.M. Lee, S.W. Park, J.S. Kim, J.K. Wang, J.Y. Kim, J.E. Lee, G.J. Ko, H.J. Pyo, Y.J. Kwon., “Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients,” Kidney Research and Clinical Practice, vol. 34, p. 20–27, 2015.
11. Widiany, F.L., Afriani, Y., “Pemantauan gizi dengan SMS reminder efektif meningkatkan kepatuhan diet pasien hemodialisis,” Jurnal Gizi Klinik Indonesia, vol. 15, no. 3, p. 89–94, 2019.
12. Linder, M.C., “Nutritional biochemistry and metabolism: with clinical application,” California, Elsevier, 2006.
13. Santos, E.J.F., E.V. Hortegal, H.O. Serra, J.S. Lages, N. Salgado-Filho, A.M. dos Santos., “Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study,” Brazilian Journal of Medical and Biological Research, vol. 51, no. 7, p. e7288, 2018.
14. Hannedouche, T., D. Fouque, D. Joly., “Metabolic complications in chronic kidney disease: hyperphosphatemia, hyperkalemia and anemia,” Nephrology & Therapeutics, vol. 14, no. 6, p. 6S17–6S25, 2018.